title: Overcoming melanoma drug resistance through metabolic targeting?
authors.affiliation: keiran.smalley@moffitt.org.
authors.forename: Keiran S M
authors.initials: KS
authors.lastname: Smalley
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D002453:Cell Cycle / Q000187:drug effects; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D006801:Humans; D008545:Melanoma / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology; D009363:Neoplasm Proteins / Q000378:metabolism; D056485:Retinoblastoma-Binding Protein 2 / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology
chemical_list: D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D056485:Retinoblastoma-Binding Protein 2